Literature DB >> 15756091

Crohn's disease patient characteristics in a tertiary referral center: comparison with patients from a population-based cohort.

Eike Zankel1, Gerhard Rogler, Tilo Andus, Carl-Michael Reng, Jürgen Schölmerich, Antje Timmer.   

Abstract

OBJECTIVES: Data on the clinical presentation, effects of therapy and prognosis of patients with Crohn's disease are often based on patients from specialized referral centers. We assessed the extent of the selection based on the clinical and demographic characteristics.
METHODS: All patients with Crohn's disease presenting to the University Hospital of Regensburg (Medical Department) were analyzed retrospectively with respect to demographic and disease specific characteristics. Only patients diagnosed <2 years before presentation were included in the main analysis. The original data from a population-based, prospectively assembled incidence cohort were available for comparison (EC-IBD, northern centers only, n=475). Age at diagnosis, disease location and behavior were categorized according to the Vienna classification. Differences were examined using chi-square tests. MAIN
RESULTS: At the referral center, 394 patients were treated within a 5-year period. Of these, 116 patients fulfilled the inclusion criteria for the comparative analysis. Sixteen percent of the referral patients were diagnosed at age 40 or older, as compared with 32% in the population-based group (P<0.004). The distribution of disease location, sex, smoking behavior and positive family history was similar in both groups. Among the referral patients, more had fistulas (39% versus 20%, P<0.001). Also, more patients were receiving steroids (49% versus 27%) or other immunosuppressive therapy (12% versus 4%). The selection effects increase with duration of disease.
CONCLUSIONS: Patients with late onset of disease, inflammatory only disease behavior and no need for immunosuppression are under-represented at a tertiary referral center.

Entities:  

Mesh:

Year:  2005        PMID: 15756091     DOI: 10.1097/00042737-200504000-00002

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  9 in total

1.  Smoking and inflammatory bowel diseases: what in smoking alters the course?

Authors:  A M El-Tawil
Journal:  Int J Colorectal Dis       Date:  2010-03-24       Impact factor: 2.571

2.  Analysis of Hospital-Based Emergency Department Visits for Inflammatory Bowel Disease in the USA.

Authors:  Mahesh Gajendran; Chandraprakash Umapathy; Priyadarshini Loganathan; Jana G Hashash; Ioannis E Koutroubakis; David G Binion
Journal:  Dig Dis Sci       Date:  2015-09-30       Impact factor: 3.199

3.  Through the endoscope balloon dilation of ileocolonic strictures: prognostic factors, complications, and effectiveness.

Authors:  Jörg C Hoffmann; Frank Heller; Siegbert Faiss; Bernd von Lampe; Anton J Kroesen; Ulrich Wahnschaffe; Jörg-Dieter Schulzke; Martin Zeitz; Christian Bojarski
Journal:  Int J Colorectal Dis       Date:  2008-03-13       Impact factor: 2.571

Review 4.  Clinical, serological and genetic predictors of inflammatory bowel disease course.

Authors:  Laurent Beaugerie; Harry Sokol
Journal:  World J Gastroenterol       Date:  2012-08-07       Impact factor: 5.742

Review 5.  Pediatric inflammatory bowel disease.

Authors:  Karen-A Diefenbach; Christopher-K Breuer
Journal:  World J Gastroenterol       Date:  2006-05-28       Impact factor: 5.742

6.  Factors affecting outcomes in Crohn's disease over 15 years.

Authors:  Jacques Cosnes; Anne Bourrier; Isabelle Nion-Larmurier; Harry Sokol; Laurent Beaugerie; Philippe Seksik
Journal:  Gut       Date:  2012-03-02       Impact factor: 23.059

7.  Factors associated with disease evolution in Greek patients with inflammatory bowel disease.

Authors:  Constantinos Chatzicostas; Maria Roussomoustakaki; Spiros Potamianos; Gregorios Paspatis; Ioannis Mouzas; John Romanos; Helen Mavrogeni; Elias Kouroumalis
Journal:  BMC Gastroenterol       Date:  2006-07-25       Impact factor: 3.067

8.  Microscopic Colitis is Associated with Several Concomitant Diseases.

Authors:  Bodil Roth; Jonas Manjer; Bodil Ohlsson
Journal:  Drug Target Insights       Date:  2013-08-11

9.  Low Incidence of Dysplasia and Colorectal Cancer Observed among Inflammatory Bowel Disease Patients with Prolonged Colonic Diversion.

Authors:  Weston Bettner; Anthony Rizzo; Steven Brant; Sharon Dudley-Brown; Jonathan Efron; Sandy Fang; Susan Gearhart; Michael Marohn; Alyssa Parian; Maryam Kherad Pezhouh; Joanna Melia; Bashar Safar; Brindusa Truta; Elizabeth Wick; Mark Lazarev
Journal:  Inflamm Bowel Dis       Date:  2018-04-23       Impact factor: 5.325

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.